Research & Development

色爱区区域综合网来射吧AV在线播放视频caoporn超碰在线视频传销黑手伸向癌症病人 "抗癌课"售价18800元骗财害人


  “曼努,不要叫了,沒有作用的。”   遠遠地听著霍去病整軍的聲音,十二個少年軍滿是羨慕之色,只有雲瑯暗暗嘆了一口氣。色爱区区域综合网   跟死亡比起來,毀容根本就不算什麼。来射吧AV在线播放视频   “帶來了多少兵馬?什麼地方的兵馬?”雲瑯一邊打開文書一邊問。   城頭的晨鐘暮鼓也被完全完善了,受降城里的人已經漸漸習慣日出而作,日落而息的漢家習慣。caoporn超碰在线视频   坐在角落里喝茶的何愁有呵呵笑道︰“只要是處子之身,老夫就沒有什麼好說的。”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo